[
  {
    "ts": "2026-03-01T11:30:44+00:00",
    "headline": "Palisade Bio Details PALI-2108 UC, Crohn’s Plans and Cash Runway Into 2029 at Oppenheimer Conference",
    "summary": "Palisade Bio (NASDAQ:PALI) executives outlined the company’s strategic pivot, lead development priorities, and financing position during a fireside chat at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference. Company background and strategic pivot Chief Executive Officer J.D. Finley said",
    "url": "https://www.marketbeat.com/instant-alerts/palisade-bio-details-pali-2108-uc-crohns-plans-and-cash-runway-into-2029-at-oppenheimer-conference-2026-03-01/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "d7b48336-2efc-3a02-8dcb-beb73afdd5b9",
      "content": {
        "id": "d7b48336-2efc-3a02-8dcb-beb73afdd5b9",
        "contentType": "STORY",
        "title": "Palisade Bio Details PALI-2108 UC, Crohn’s Plans and Cash Runway Into 2029 at Oppenheimer Conference",
        "description": "",
        "summary": "Palisade Bio (NASDAQ:PALI) executives outlined the company’s strategic pivot, lead development priorities, and financing position during a fireside chat at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference. Company background and strategic pivot Chief Executive Officer J.D. Finley said",
        "pubDate": "2026-03-01T11:30:44Z",
        "displayTime": "2026-03-01T11:30:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/09d0c56e03a96053a6bee961ce173fe3",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Palisade Bio logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GwPimsaj4is00_aQf_Ygfg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/09d0c56e03a96053a6bee961ce173fe3.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/egfHagReAxuCMGULmi.Ojw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/09d0c56e03a96053a6bee961ce173fe3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/palisade-bio-details-pali-2108-uc-crohns-plans-and-cash-runway-into-2029-at-oppenheimer-conference-2026-03-01/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/palisade-bio-details-pali-2108-113044238.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PALI"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]